Fitbit Can Assist Doctors To Envisage How Patients Will Respond To Chemotherapy


Wearable fitness trackers, for instance, the famous Fitbit, have the prospective to assist the doctors to assess which patients will perform well on a chemotherapy course and be capable of intervening prior to unanticipated admissions to the hospital, believe experts.

Researchers from the University of Southern California stated that doctors, in the future, may be capable of using the technology in several manners, such as to estimate which patients wouldn’t do fine in clinical trials. In particular, cancer researchers have inclined toward fitness trackers as a means to impartially evaluate the quality of life of patients.

The new trial monitored 65 individuals with solid tumors undertaking complex chemotherapy courses with medications probable to cause grave side-effects, such as vomiting and nausea. The team evaluated the physical activity of patients from 10 am to 7 pm using a Microsoft fitness band for 60 Days, and then gathered their information from smartphone applications.

Only 9 out of 41 individuals measured got over 60 Hours of lively activity, however, those patients had “considerably” fewer unanticipated hospitalizations. The team said active patients were getting up, cleaning, or cooking for over an hour every 3 Days and thus, were less prone to have any adverse events.

Now, cancer researchers are examining whether fitness trackers can be devices to compute a quality of life of a patient. Researchers at Johns Hopkins University, MD Anderson Cancer Center, and Dana-Farber Cancer Institute have all gathered information from a scientific product of Fitbit, Fitabase. Experts, in the future, anticipate to be capable of scrutinizing a patient’s physical activity level in real time, the similar as the patient may but distantly, through the fitness tracker resting on their wrist.

Apart from this, LifePlus Inc., a personal care startup, has declared its entry into the smart medical wearable technology sector with the launch of “Lifeleaf”—that it states to be the foremost non-invasive constant blood glucose monitoring multisensor wearable device of the world.

Leave A Reply

Your email address will not be published.